News

EXCLUSIVE: Lipsync Post, the 40-year-old British post-production house and film investor, has effectively filed for Chapter 11 bankruptcy. Lipsync, which boasts credits including The Brutalist and ...
Russell Brand has pleaded not guilty to charges of rape, indecent assault and sexual assault. His trial will begin on June 3 2026. The TV presenter-turned MAGA outrider appeared in London’s ...
HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...
This was buoyed by a 28% leap year-on-year (YoY) in revenues to SAR 97.4 million, as well as attraction of new customers and launch of new products. However, this was offset by higher general, ...
TME Pharma N.V. (Euronext Growth Paris: ALTME),a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
"We are very excited about the patent approval of our topical pain relief technology in Mexico," said Iris Bincovich, Chief Executive Officer of Innocan Pharma. Innocan Pharma intends to continue ...
The approval of LED BLU-U was granted under FDA's Real-Time Review Program, reflecting the robustness of the submission and Sun Pharma's continued collaboration with the Agency. The LED BLU-U will ...
"We are excited to enter the next phase of Ousia Pharma's journey, advancing our groundbreaking platform towards clinical development," said Anders B. Klein, PhD, CEO of Ousia Pharma. "The strong ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
The Company is hereby clarifying and providing additional information on the financing announced on May 21, 2025 TME Pharma has secured private binding commitments from professional European ...
Ladun Investment Co.’s shareholders will vote on transferring the entire statutory reserve balance of SAR 30.64 million, as in the 2024 income statement, to retained earnings, during an extraordinary ...
IGC Pharma Inc. Annual stock financials by MarketWatch. View the latest IGC financial statements, income statements and financial ratios. Skip to main content Main Menu Latest News Watchlist ...